Method for treatment of malignant and infectious chronic diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Jul 5, 2006
filing date -
Dec 4, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention relates to methods of treatment useful in chronic diseases, by means of breaking tolerance to self-antigens and increasing autoimmune response against these antigens. More particularly, the present invention relates to methods useful in the treatment of tumors that are growth dependent on the Epidermal Growth Factor. The present invention provides a therapeutic combination that includes the combination of a vaccine against self antigens with a monoclonal antibody against peripheral T cells or a chemotherapeutic drug able to induce a depletion of peripheral T cells. The present invention also provides a method of treatment of chronic diseases in which the rupture of the tolerance to self antigens is essential for the control of the disease, by administering an immune suppressor agent between two cycles of vaccination against a self antigen, for example EGF, for effective treatment for the reduction of tumors whose growth depends on EGF.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully